Dr. Lisieski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Glendale Ave
Toledo, OH 43614Phone+1 419-383-5502Fax+1 419-383-5515
Education & Training
- University of ToledoResidency, Family Medicine, 2020 - 2023
- Wayne State University School of MedicineClass of 2018
Certifications & Licensure
- OH State Medical License 2020 - 2025
- American Board of Family Medicine Family Medicine
Publications & Presentations
PubMed
- Corrigendum to "D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats" [Eur. J. Pharmacol. 862 (2019)...Aloke K Dutta, Soumava Santra, Arman Harutyunyan, Banibrata Das, Michael J Lisieski
European Journal of Pharmacology. 2022-10-15 - Corrigendum to "D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats" [Eur. J. Pharmacol. 862 (2019)...Aloke K Dutta, Soumava Santra, Arman Harutyunyan, Banibrata Das, Michael J Lisieski
European Journal of Pharmacology. 2022-09-15 - 6 citationsD-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats.Aloke K. Dutta, Soumava Santra, Arman Harutyunyan, Banibrata Das, Michael J. Lisieski
European Journal of Pharmacology. 2019-11-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: